Xencor
XNCR
#5517
Rank
ยฃ0.94 B
Marketcap
ยฃ13.26
Share price
2.20%
Change (1 day)
-32.91%
Change (1 year)

Revenue for Xencor (XNCR)

Revenue in 2025 (TTM): ยฃ0.12 Billion

According to Xencor's latest financial reports the company's current revenue (TTM ) is ยฃ0.12 Billion. In 2024 the company made a revenue of ยฃ0.10 Billion a decrease over the revenue in the year 2023 that were of ยฃ0.13 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Xencor from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0.12 B26.27%
2024 ยฃ0.10 B-22.98%
2023 ยฃ0.13 B-2.87%
2022 ยฃ0.13 B-33.25%
2021 ยฃ0.20 B126.42%
2020 ยฃ90.01 M-24.67%
2019 ยฃ0.11 B273.59%
2018 ยฃ31.98 M60.47%
2017 ยฃ19.93 M-71.9%
2016 ยฃ70.92 M278.62%
2015 ยฃ18.73 M206.37%
2014 ยฃ6.11 M-0.84%
2013 ยฃ6.16 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Seagen
SGEN
ยฃ1.72 B 1,274.52%๐Ÿ‡บ๐Ÿ‡ธ USA
MacroGenics
MGNX
ยฃ94.5 M-24.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ26.97 B 21,393.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ48.17 B 38,282.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ69.11 B 54,961.34%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ44.73 B 35,538.78%๐Ÿ‡บ๐Ÿ‡ธ USA